CBS News @CBSNews
A drug initially developed in hopes of treating cancer patients could significantly cut the risk of death among hospitalized COVID-19 patients who are at high risk of severe disease, results published on Wednesday suggest. https://t.co/k0qdkPSPFM — PolitiTweet.org